(Press-News.org) The sickle cell trait could be a cause—albeit rare—of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions, April 1-3, in New Orleans.
The sickle cell trait (SCT), which affects approximately 8 percent of African-Americans in the U.S., has been associated with sudden death in military recruits undergoing vigorous exercise. Due to the potential hypothesis that SCT may also cause sudden death in young highly trained athletes during physical activity, the National Collegiate Athletic Association (NCAA) has recently made screening of athletes for SCT mandatory for all Division I athletes prior to their participation in college athletics.
However, Kevin M. Harris, MD, co-director of the Acute Aortic Dissection Program and director of the echocardiography laboratory at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, pointed out that there are little data available documenting cases of SCT-related sudden death in athletes.
"Originally, the sickle cell trait was considered a benign condition," said Harris, who is the study's lead author. "However, studies began to demonstrate that in extreme physical situations, such as military recruit training, some individuals with SCT can be at risk for dying suddenly. Then, we began to see the same occurrences in athletes."
Therefore, Harris and colleagues accessed the 30-year U.S. National Registry of Sudden Death in Athletes, which is maintained by the Minneapolis Heart Institute Foundation, in order to determine the frequency and profile of SCT deaths.
Of the 2,387 deaths recorded in the registry, 22 of the athletes who died had SCT—15 of whom SCT was considered the primary cause of death (or approximately 1 percent). Of those who died, the athletes were approximately 18.5 years of age, all were African-American and 20 were male.
All the athletes died during physical exertion including practice (21 individual) or a game (one individual). Of the 22 SCT deaths, 18 were engaged in football, three in basketball and one in track. Eleven athletes incurred rhabdomyolysis as a complication of SCT.
Interestingly, only one of these events occurred at high altitude, even though it has been considered a predictor of sudden death among individuals with SCT. However, environmental conditions, such as heat or humidity and dehydration could not be excluded as contributing factors, underscoring the importance of "water breaks for young athletes," Harris said. "Particularly, if an athlete is identified as having SCT, proper precautions need to be taken, and the coaching staff should be made aware."
"These data also underscore the prudence of recent initiatives for pre-participation screening to prospectively identify sickle cell trait in athletes," the study authors concluded.
###
Minneapolis Heart Institute®
The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.
Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.
Young black athletes with sickle cell trait might be susceptible to sudden death
2011-04-03
ELSE PRESS RELEASES FROM THIS DATE:
Scientists identify KRAS rearrangements in metastatic prostate cancer
2011-04-03
ORLANDO, Fla. — Scientists have uncovered a genetic characteristic of metastatic prostate cancer that defines a rare sub-type of this disease. These findings are published in Cancer Discovery, the newest journal of the American Association for Cancer Research, which will debut at the AACR 102nd Annual Meeting 2011, held April 2-6.
Arul M. Chinnaiyan, M.D., Ph.D., an investigator of the Howard Hughes Medical Institute and director of the Michigan Center for Translational Pathology, and colleagues identified an oncogenic gene fusion of KRAS, one of the most studied and ...
New target identified for squamous cell lung cancer
2011-04-03
ORLANDO, Fla. — Scientists at the Dana Farber Cancer Institute have identified a mutation in the DDR2 gene that may indicate which patients with squamous cell lung cancer will respond to dasatinib.
The findings are published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, from April 2-6.
According to lead researcher Matthew Meyerson, M.D., Ph.D., professor of pathology at the Dana Farber Cancer Institute, there are currently no targeted therapies for squamous cell lung cancer, ...
Immune system may guide chemotherapy for breast cancer
2011-04-03
ORLANDO, Fla. — A study published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, held April 2-6, showed how evaluating the immune response in the tumor microenvironment may help researchers better target therapy in breast cancer.
Researchers at the University of California, San Francisco, demonstrated that the level of macrophages and CD8+ T-cells, two key components of the human immune system, can help predict recurrence and overall survival. New biologic-targeted therapies ...
Digoxin may be a possible treatment for prostate cancer
2011-04-03
ORLANDO, Fla. — Scientists have identified digoxin as a possible therapy for prostate cancer, using a combination of laboratory science and epidemiology that is unprecedented in its cooperative nature.
"Epidemiologists and basic scientists often do not understand each other, as we often are only clear on our own strengths and the other's weaknesses," said Elizabeth Platz, Sc.D., M.P.H, professor of epidemiology and the Martin D. Abeloff, M.D., scholar in cancer prevention at Johns Hopkins University.
For the current paper, published in Cancer Discovery, the newest ...
Large Veterans Health Administration study shows 'last resort' antibiotics use on the rise
2011-04-03
Dallas, TX (April 3, 2011) – A large, multi-year study of antibiotic use in Veterans Health Administration's acute care facilities demonstrates dramatically increased use of carbapenems, a powerful class of antibiotics, over the last five years. These drugs are often considered the last treatment option for severe infections with multi-drug resistant pathogens. The increased carbapenem use, which has also been described in non-VA facilities in the US, is alarming because carbapenem-resistant bacteria are becoming more common. Overuse of these drugs could weaken their efficacy, ...
Search for advanced materials aided by discovery of hidden symmetries in nature
2011-04-03
A new way of understanding the structure of proteins, polymers, minerals, and engineered materials will be published in the May 2011 issue of the journal Nature Materials. The discovery by two Penn State University researchers is a new type of symmetry in the structure of materials, which the researchers say greatly expands the possibilities for discovering or designing materials with desired properties. The research is expected to have broad relevance in many development efforts involving physical, chemical, biological, or engineering disciplines including, for example, ...
Heart drug cuts prostate cancer risk; holds potential for therapeutic use
2011-04-03
Johns Hopkins scientists and their colleagues paired laboratory and epidemiologic data to find that men using the cardiac drug, digoxin, had a 24 percent lower risk for prostate cancer. The scientists say further research about the discovery may lead to use of the drug, or new ones that work the same way, to treat the cancer.
Digoxin, made from the foxglove plant, has been used for centuries in folk medicine and for decades to treat congestive heart failure and heart rhythm abnormalities. It also emerged as a leading candidate among 3,000 drugs screened by the Johns ...
Nanoparticles offer hope for common skin allergy
2011-04-03
Boston, MA - Tiny particles only billionths of a meter in diameter—about two thousand would fit across the width of a human hair—could offer big hope in a small package to the many millions of people who are allergic to the nickel in everything from jewelry to coins and cell phones, say scientists at Brigham and Women's Hospital (BWH).
In the April 3 online issue of Nature Nanotechnology, the team will report a new approach to preventing the common skin allergy.
Approximately ten to fifteen percent of the US population, or over 30 to 45 million people, plus many more ...
BestSlots.co.uk Wins Endorsement From eCOGRA for Its Online Slots Guide
2011-04-03
Following a successful first year online delivering independent consumer news and reviews for UK online slots enthusiasts, BestSlots.co.uk has cemented its reputation for trustworthy content and service with recognition by eCOGRA (eCommerce and Online Gaming Regulation and Assurance) as one of its Reputable Portals.
The eCOGRA organisation is a non-profit, independent regulatory body that was formed with a mission to protect players by addressing the need for fair gaming and responsible operator conduct, setting standards for the online gaming industry that are enforced ...
Regional prevention project involving 10,000 adults cuts heart attacks by 25 percent
2011-04-03
The Heart of New Ulm Project, which is merging environmental, peer leadership and individual interventions across an entire rural Minnesota community with the assistance of a healthcare system, worksites and the general community to prevent coronary heart disease, has shown a 24 percent reduction in the number of acute heart attacks in a five-quarter period, compared with the previous five-quarter period of evaluation.
This study will be presented at the 60th annual American College of Cardiology (ACC) Scientific Sessions in New Orleans on April 3.
“Hearts Beat Back: ...